Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. Guided by our core values, we incorporate unconventional approaches through strong partnerships with industry leaders, scientists, doctors and organizations. We work collaboratively across everything we do to positively impact the lives of patients and their families.
Company’s Keywords:
als, neurodegenerative diseases, alzheimers, alzheimers disease, amyotrophic lateral sclerosis
230
pharmaceuticals
285000
NetSuite, Salesforce, Mimecast, Amazon AWS, Adobe Marketing Cloud, Media Temple SSL, OneTrust, Google Tag Manager, New Relic, Mobile Friendly, Nginx, Active Campaign, Varnish, Bootstrap Framework, reCAPTCHA, Google Font API
2013